drospirenone has been researched along with Breast Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y | 1 |
| Baldacci, C; Flamini, MI; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Goglia, L; Sanchez, AM; Simoncini, T; Sitruk-Ware, R | 1 |
| Genazzani, AR; Simoncini, T | 1 |
| Wallis, L | 1 |
| Yuzpe, AA | 1 |
| Bray, JA; Bray, JD; Brown, EL; Ghatge, R; Horwitz, KB; Jacobsen, BM; Jelinsky, S; Lyttle, CR; Richer, JK; Saraf, K; Tunkey, C; Winneker, RC | 1 |
| Skouby, SO | 1 |
3 review(s) available for drospirenone and Breast Neoplasms
| Article | Year |
|---|---|
A review of the cardiovascular and breast actions of drospirenone in preclinical studies.
Topics: Androstenes; Animals; Breast; Breast Neoplasms; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Progestins; Risk Factors | 2010 |
Oral contraception: trends over time.
Topics: Adult; Androstenes; Breast Neoplasms; Contraception; Contraceptives, Oral, Combined; Contraindications; Ethinyl Estradiol; Female; Humans; Middle Aged; Patient Compliance; Pregnancy; Progestins; Risk Factors; Thrombosis | 2002 |
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
4 other study(ies) available for drospirenone and Breast Neoplasms
| Article | Year |
|---|---|
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone | 2019 |
Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion.
Topics: Actins; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cytoskeleton; Estradiol; Humans; Medroxyprogesterone Acetate; Microfilament Proteins; Neoplasm Invasiveness; Norprogesterones; Progesterone; Signal Transduction | 2008 |
Beyond politics: new medical concerns for contraceptive users.
Topics: Administration, Cutaneous; Adult; Androstenes; Breast Neoplasms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone Acetate; Mineralocorticoid Receptor Antagonists; Thrombosis; United States | 2012 |
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
Topics: Alkaline Phosphatase; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Desogestrel; Dose-Response Relationship, Drug; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Levonorgestrel; Ligands; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Progesterone; Progestins; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transcription, Genetic | 2005 |